Brief: Rani Therapeutics Announces Closing Of Oversubscribed $60.3 Million Private Placement Priced At-The-Market Under Nasdaq Rules
23/10/2025 23:37
Oct 24 (Reuters) - Rani Therapeutics Holdings Inc RANI.O: RANI THERAPEUTICS ANNOUNCES CLOSING OF OVERSUBSCRIBED $60.3 MILLION PRIVATE PLACEMENT PRICED AT-THE-MARKET UNDER NASDAQ RULES Source text: ID:nGNX6p9Sfg Further company coverage: RANI.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rani Therapeutics Holdings
See all newsRani Therapeutics Q2 net loss narrows as revenue rises helped by Chugai agreement
Brief: Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: Pegbio Co Enters MoU With Rani Therapeutics
Brief: Rani Therapeutics Announces R&D Collaboration With PegBio
Rani Therapeutics Q1 contract revenue rises on Chugai collaboration; announces CFO transition